New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

Africa’s pharmaceutical future is at a critical juncture with developments shedding light on the continent’s reliance on external aid for vaccine access. The Trump administration’s initial freeze on ...

The company – led by Mark McKenna ... It was led by venture capital firm ARCH Venture Partners, with other prominent biotech investors participating, including OrbiMed, Fairmount, Fidelity ...

PDS Biotechnology (PDSB) reaffirmed the Company’s guidance of initiating its VERSATILE-003 Phase 3 clinical trial of Versamune HPV plus ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Pacific Biosciences has moved into its new headquarters at 1305 O'Brien Drive in the Menlo Park Labs office complex in Menlo ...

The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...